VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
STSS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
STSSSharps Technology, Inc.
$1.13$48M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSTSSBalance Sheet

Sharps Technology, Inc. (STSS) Balance Sheet

7Y historyFree accessUpdated daily

The balance sheet exhibits significant instability, with total assets declining from $444.0 million in 2025Q3 to $181.0 million in 2026Q1, alongside a complete write-down of $250.1 million in goodwill.

STSS Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Total Current Assets18.38M11.23M3.17M4.84M4.42M1.61M1.84M635.5K
Cash & Short-Term Investments12.32M10.38M864.04K3.01M4.17M1.48M1.79M635.5K
Cash Only12.32M10.38M864.04K3.01M4.17M1.48M1.79M635.5K
Short-Term Investments00000000
Accounts Receivable396.9K711.96K102.49K47.95K0000
Days Sales Outstanding693.721.27K------
Inventory457.71K645.27K1.87M1.71M185.8K121.99K00
Days Inventory Outstanding387.25381.45880.86699.96103.611.55K--
Other Current Assets5.21M-7.17M250K00000
Total Non-Current Assets162.62M81.17K4.14M6.95M7.42M4.29M391.87K25.9K
Property, Plant & Equipment58.83K81.17K4.04M6.82M7.34M3.76M316.87K25.9K
Fixed Asset Turnover0.34x2.51x------
Goodwill00000000
Intangible Assets0250.11M32.5K52.51K62.48K000
Long-Term Investments404.2M0000000
Other Non-Current Assets162.56M-250.11M72.2K76.06K12.37K529.86K75K0
Total Assets181M269.08M7.31M11.79M11.84M5.9M2.23M661.4K
Asset Turnover0.00x0.00x------
Asset Growth %8352.87%3579.03%-37.96%-0.43%100.59%164.43%237.47%-
Total Current Liabilities2.22M4.7M5.19M3.69M2.01M2.77M101.25K100.49K
Accounts Payable1.58M590.69K976.55K794.11K543.23K804.14K101.25K100.49K
Days Payables Outstanding534.07349.19460.57325.22302.9110.23K3.35K3.46K
Short-Term Debt03.08M3.76M00700.01K00
Deferred Revenue (Current)00000000
Other Current Liabilities637.73K1.02M98.91K2.42M1.15M585K00
Current Ratio8.28x2.39x0.61x1.31x2.20x0.58x18.18x6.32x
Quick Ratio8.08x2.25x0.25x0.85x2.11x0.54x18.18x6.32x
Cash Conversion Cycle546.91.31K------
Total Non-Current Liabilities00132K162K192K000
Long-Term Debt00000000
Capital Lease Obligations00000000
Deferred Tax Liabilities264K0132K162K192K000
Other Non-Current Liabilities00000000
Total Liabilities2.22M4.7M5.32M3.85M2.2M2.77M101.25K100.49K
Total Debt03.08M3.76M00700.01K00
Net Debt-12.32M-7.3M2.9M-3.01M-4.17M-779.15K-1.79M-635.5K
Debt / Equity0.00x0.01x1.89x--0.22x--
Debt / EBITDA-0.00x-------
Net Debt / EBITDA0.78x-------
Interest Coverage-2260.15x-647.82x-4.47x--2.51x-26.84x--
Total Equity178.78M264.38M2M7.93M9.64M3.14M2.13M560.92K
Equity Growth %21469.05%13144.64%-74.84%-17.7%207.41%47.18%279.88%-
Book Value per Share2.4610.45476.744019.407857.482257.881534.07403.83
Total Shareholders' Equity178.78M264.38M2M7.93M9.64M3.14M2.13M560.92K
Common Stock4.03K2.9K2051.53K9415194601.38K
Retained Earnings-403.19M-316.95M-34.45M-25.15M-15.31M-10.67M-6M-3.66M
Treasury Stock00000000
Accumulated OCI0023.29K591.81K214.25K000
Minority Interest00000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Capital exhaustion and dilution

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Balance Sheet Volatility Reflects Instability

As reported in recent financial filings, the company's total assets fluctuated from $181.0 million in 2026Q1 down from $444.0 million in 2025Q3, signaling a highly unstable capital base that appears to be struggling to find a sustainable equilibrium for its early-stage medical device operations.

The dramatic swings in asset levels suggest that the company is undergoing significant balance sheet restructuring or revaluation, which may indicate underlying uncertainty regarding the carrying value of its assets. Investors should monitor whether this volatility stems from asset impairment or erratic capital raising activities that fail to provide a stable foundation for growth.

Liquidity Buffer Facing Rapid Erosion

Based on the company's reported figures, the current ratio of 8.28 in 2026Q1 masks a precarious cash position, as the firm's cash reserves of $12.3 million are being rapidly depleted by persistent operating losses and a lack of meaningful revenue generation to offset ongoing burn.

While the high current ratio might appear favorable at first glance, it likely reflects a lack of significant short-term liabilities rather than a robust liquidity position. The company's reliance on its remaining cash balance to fund operations suggests that liquidity will continue to tighten unless a major commercial breakthrough occurs.

Equity Quality Diluted by Losses

According to the provided balance sheet data, the company's retained earnings have plummeted to -$403.2 million as of 2026Q1, indicating that historical capital has been largely consumed by operating deficits rather than being reinvested into productive, value-accretive assets for the business.

The erosion of equity highlights the significant value destruction that has occurred as the company attempts to commercialize its technology. This trend suggests that future growth may require further dilutive financing, which could continue to pressure shareholder value in the absence of a clear path to profitability.

Goodwill Impairment Risks Loom Large

As evidenced by the dramatic shift in goodwill from $250.1 million in 2025Q4 to zero in 2026Q1, the company's balance sheet appears highly sensitive to accounting adjustments that may obscure the true economic value of its intangible assets and intellectual property portfolio.

The sudden disappearance of goodwill warrants deep investigation, as it may indicate that previous acquisitions or internal valuations were significantly overstated. This volatility suggests that the book value of the company may not be a reliable indicator of its actual worth in a liquidation or acquisition scenario.

STSS — Frequently Asked Questions

Quick answers to the most common questions about buying STSS stock.

What are the total assets of Sharps Technology, Inc. (STSS)?

As of 2025, Sharps Technology, Inc. (STSS) had total assets of $269.1M including $11.2M in current assets.

How much debt does Sharps Technology, Inc. (STSS) have?

Sharps Technology, Inc. (STSS) carries total debt of $3.1M, offset by $10.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Sharps Technology, Inc.?

Sharps Technology, Inc. (STSS) has total shareholders' equity (book value) of $264.4M ($10.45 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Sharps Technology, Inc.'s current ratio and liquidity?

Sharps Technology, Inc. (STSS) reported a current ratio of 2.39x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.